NCT07505784

Brief Summary

The aim of the study is to evaluate the safety, feasibility, clinical and biological efficacy, and predictors of efficacy of an intervention consisting of transcranial alternating current stimulation (tACS) in patients with Frontotemporal Dementia (FTD). In addition to typical symptoms, FTD also present alterations in brain oscillations. In animal models of neurodegeneration, restoration of oscillations via neuronal "entrainment" phenomena has demonstrated a significant reduction in toxic protein accumulation, resulting in improved cognitive function. tACS is a neurophysiological noninvasive method of neuromodulation increasingly studied for its therapeutic potential. It has been shown to safely modulate the oscillatory frequencies underlying multiple cognitive functions, including verbal memory, perception, and working memory. In light of this evidence, it is proposed to apply a single-session treatment of β-tACS stimulation in patients with FTD and to evaluate its clinical effects, oscillatory modifications by EEG, and changes in neurophysiological indices such as short intracortical inhibition (SICI) and intracortical facilitation (ICF), both compromised in the disease. The study has a cross-over design (multicenter, randomized, placebo-controlled and double-blind), with FTD patients randomly assigned to one of the two arms: i) Group 1, who will receive a real tACS session first (1h); ii) Group 2, who will instead undergo a sham tACS session (1h). In the next phase (cross-over), one week after the first phase, the groups will reverse the treatment: Group 1 will receive tACS sham and Group 2 will receive real tACS. The main objectives of the study are: \[1\] to evaluate the safety and tolerability of the single tACS treatment session; \[2\] to investigate the effects of the protocol on (short-term) cognitive performance in patients with FTD; \[3\] to verify intervention-induced changes in brain synchronization; \[4\] to evaluate changes in neurophysiological indices following treatment; and \[5\] evaluate any predictors of efficacy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
9mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Feb 2026Feb 2027

Study Start

First participant enrolled

February 3, 2026

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 23, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

April 1, 2026

Status Verified

February 1, 2026

Enrollment Period

10 months

First QC Date

February 23, 2026

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (8)

  • Safety and Feasibility of Transcranial Alternating Current Stimulation Protocol

    Safety will be assessed in terms of the frequency and severity of any adverse events, and feasibility will be assessed based on the study dropout rate. Safety and feasibility will be monitored throughout the study.

    Periprocedurally, an average 1 week

  • Phonemic Fluency Test

    Cognitive flexibility and verbal fluency will be evalueted by Phonemic Fluency Test. Subject is asked to generate as many words as possible from a given letter within a limited time (60 seconds); higher scores indicate better perfomance.

    Immediately before and immediately after first stimulation. Immediately before and immediately after second stimulation, after a week.

  • Semantic Fluency Test

    Lexical-semantic access and executive functioning will be evalueted by Semantic Fluency Test. Subject is asked to generate as many words as possible from a given category within a limited time (60 seconds); higher scores indicate better perfomance.

    Immediately before and immediately after first stimulation. Immediately before and immediately after second stimulation, after a week.

  • Trail Making Test (TMT - AB)

    Executive function will be assessed using the Trail Making Test, including Part A (visual attention and processing speed) and Part B (task switching and cognitive flexibility). Higher completion times reflect poorer performance.

    Immediately before and immediately after first stimulation. Immediately before and immediately after second stimulation, after a week.

  • Digit Span Test

    Short-term memory and working memory will be assessed respectively using the Digit Span forward and Digit Span backward. Scores reflect the maximum number of digits recalled in correct order.

    Immediately before and immediately after first stimulation. Immediately before and immediately after second stimulation, after a week.

  • Modified Emotion Recognition Test

    Emotion recognition from facial expressions will be evalueted by Modified Emotion Recognition Test. Subject is asked to choose an emotion from five options for each face showed; higher scores indicate better perfomance.

    Immediately after first stimulation. Immediately after second stimulation, after a week.

  • Berg's Card Sorting Task

    Cognitive flexibility and problem solving will be assessed by Berg's Card Sorting Task. Scores reflect correct answer, errors and reaction time.

    At the end of first stimulation. At the end of second stimulation, after a week.

  • Go/No-Go Task

    Inhibition control will be assessed by Go/No-Go Task. Scores reflect correct targets, false alarms, misses and response speed.

    At the end of first stimulation. At the end of second stimulation, after a week.

Secondary Outcomes (3)

  • Change in electroencephalography (EEG)

    Immediately before and immediately after first stimulation. Immediately before and immediately after second stimulation, after a week.

  • Effectiveness in restoring neurotransmission

    Immediately before and immediately after first stimulation. Immediately before and immediately after second stimulation, after a week.

  • Demographic characteristics

    Baseline

Study Arms (2)

Group 1

OTHER

Group 1, who will undergo real tACS treatment, in a single 60-minute session and after one week of sham tACS treatment, in a single 60-minute session.

Device: Transcranial Alternating Current StimulationDevice: Sham Transcranial Alternating Current Stimulation

Group 2

OTHER

Group 2, who will undergo sham tACS treatment, in a single 60-minute session and after one week of real tACS treatment, in a single 60-minute session.

Device: Transcranial Alternating Current StimulationDevice: Sham Transcranial Alternating Current Stimulation

Interventions

The session will consist of the application of a session of tACS (real at 2.5 mA) at the cortical level for a duration of 60 minutes.

Group 1Group 2

Application of sham tACS session at the cortical level for a duration of 60 minutes. The electrode placement will be identical to that used for real stimulation. However, the electrical current will be automatically interrupted approximately 30 seconds after the start of stimulation, making it impossible for the patient to distinguish between sham and real stimulation.

Group 1Group 2

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female subjects aged over 40 years at the time of signing the informed consent form;
  • Presence of a clinical diagnosis of Frontotemporal Dementia according to clinical criteria (Rascovsky et al., 2011; Gorno-Tempini et al., 2011).

You may not qualify if:

  • Inability to understand;
  • Contraindications for tACS and TMS: cardiac pacemaker carriers and metal implants that are not compatible with electric or magnetic fields, history of epilepsy, current pregnancy (Safety Questionnaire)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Centro San Giovanni Di Dio - Fatebenefratelli

Brescia, BS, 25125, Italy

RECRUITING

Related Publications (15)

  • Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., Van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., Hillis, A. E., Josephs, K. A., Boeve, B. F., Kertesz, A., Seeley, W. W., Rankin, K. P., Johnson, J. K., Gorno-Tempini, M.-L., Rosen, H., … Miller, B. L. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(9), 2456-2477. https://doi.org/10.1093/brain/awr179

    RESULT
  • Pettorruso, M., Miuli, A., Di Natale, C., Montemitro, C., Zoratto, F., De Risio, L., d'Andrea, G., Dannon, P. N., Martinotti, G., & Di Giannantonio, M. (2021). Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review. Addictive Behaviors, 112, 106657. https://doi.org/10.1016/j.addbeh.2020.106657

    RESULT
  • Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F, Pascual-Leone A. Transcranial direct current stimulation: State of the art 2008. Brain Stimul. 2008 Jul;1(3):206-23. Epub 2008 Jul 1. Review.

    RESULT
  • Nishida, K., Yoshimura, M., Isotani, T., Yoshida, T., Kitaura, Y., Saito, A., Mii, H., Kato, M., Takekita, Y., Suwa, A., Morita, S., & Kinoshita, T. (2011). Differences in quantitative EEG between frontotemporal dementia and Alzheimer's disease as revealed by LORETA. Clinical Neurophysiology, 122(9), 1718-1725. https://doi.org/10.1016/j.clinph.2011.02.011

    RESULT
  • Monaco M, Costa A, Caltagirone C, Carlesimo GA. Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol Sci. 2013;34(5):749-54.

    RESULT
  • Lindau, M., Jelic, V., Johansson, S.-E., Andersen, C., Wahlund, L.-O., & Almkvist, O. (2003). Quantitative EEG Abnormalities and Cognitive Dysfunctions in Frontotemporal Dementia and Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders, 15(2), 106-114. https://doi.org/10.1159/000067973

    RESULT
  • Iyer, M. B., Mattu, U., Grafman, J., Lomarev, M., Sato, S., & Wassermann, E. M. (2005). Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology, 64(5), 872-875. https://doi.org/10.1212/01.WNL.0000152986.07469.E9

    RESULT
  • Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., Manes, F., Dronkers, N. F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B. L., Knopman, D. S., Hodges, J. R., Mesulam, M. M., & Grossman, M. (2011). Classification of primary progressive aphasia and its variants. Neurology, 76(11), 1006-1014. https://doi.org/10.1212/WNL.0b013e31821103e6

    RESULT
  • Costa A, Bagoj E, Monaco M, et al. Standardization and normative data obtained in the Italian population for a new verbal fluency instrument, the phonemic/semantic alternate fluency test. Neurol Sci. 2014;35(3):365- 372. doi:10.1007/s10072-013-1520-8

    RESULT
  • Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002;22(6):443-447. doi:10.1007/s100720200003

    RESULT
  • Benussi, A., Grassi, M., Palluzzi, F., Koch, G., Di Lazzaro, V., Nardone, R., Cantoni, V., Dell'Era, V., Premi, E., Martorana, A., Di Lorenzo, F., Bonnì, S., Ranieri, F., Capone, F., Musumeci, G., Cotelli, M. S., Padovani, A., & Borroni, B. (2020). Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias. Annals of Neurology, 87(3), 394-404. https://doi.org/10.1002/ana.25677

    RESULT
  • Benussi, A., Cantoni, V., Rivolta, J., Zoppi, N., Cotelli, M. S., Bianchi, M., Cotelli, M., & Borroni, B. (2024). Alpha tACS Improves Cognition and Modulates Neurotransmission in Dementia with Lewy Bodies. Movement Disorders, 39(11), 1993-2003. https://doi.org/10.1002/mds.29969

    RESULT
  • Benussi, A., Cantoni, V., Grassi, M., Brechet, L., Michel, C. M., Datta, A., Thomas, C., Gazzina, S., Cotelli, M. S., Bianchi, M., Premi, E., Gadola, Y., Cotelli, M., Pengo, M., Perrone, F., Scolaro, M., Archetti, S., Solje, E., Padovani, A., … Borroni, B. (2022). Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease. Annals of Neurology, 92(2), 322-334. https://doi.org/10.1002/ana.26411

    RESULT
  • Antal A, Alekseichuk I, Bikson M, Brockmöller J, Brunoni AR, Chen R, Cohen LG, et al. Low Intensity Transcranial Electric Stimulation: Safety, Ethical, Legal Regulatory and Application Guidelines. Clin Neurophysiol. 2017 Sep;128(9):1774-1809.

    RESULT
  • Amodio P, Wenin H, Del Piccolo F, et al. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res. 2002;14(2):117-131. doi:10.1007/BF03324425

    RESULT

MeSH Terms

Conditions

Frontotemporal Dementia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Frontotemporal Lobar DegenerationDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTDP-43 ProteinopathiesNeurodegenerative DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study is a randomized, double-blind, cross-over study designed to evaluate the effects of tACS on cognitive performance and neurophysiological parameters.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 23, 2026

First Posted

April 1, 2026

Study Start

February 3, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

April 1, 2026

Record last verified: 2026-02

Locations